Allianz Asset Management’s Editas Medicine EDIT Stock Holding History

Allianz Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,655	Closed	-$536K	–	2199
2020 Q4	$536K	Buy	+7,655	New	+$314K	﹤0.01%	1619
2019 Q2	–	Sell	-65,360	Closed	-$1.6M	–	2694
2019 Q1	$1.6M	Sell	65,360 -16,615	-20%	-$376K	﹤0.01%	1921
2018 Q4	$1.82M	Sell	81,975 -328	-0.4%	-$8.93K	﹤0.01%	1801
2018 Q3	$2.62M	Sell	82,303 -74,590	-48%	-$2.41M	﹤0.01%	1840
2018 Q2	$5.62M	Buy	156,893 +15,798	+11%	+$559K	0.01%	1472
2018 Q1	$4.68M	Buy	141,095 +275	+0.2%	+$9.8K	﹤0.01%	1560
2017 Q4	$4.33M	Buy	140,820 +4,915	+4%	+$124K	﹤0.01%	1694
2017 Q3	$3.26M	Buy	+135,905	New	+$2.59M	﹤0.01%	1824

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management's EDIT Position: Q1 2021 in Review

Allianz Asset Management sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 7,655 shares — an estimated $536K sold.

Allianz Asset Management first reported a position in EDIT in Q3 2017 and held it in 8 quarters. The position peaked at $5.62M in Q2 2018. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

Allianz Asset Management reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
Allianz Asset Management sold 7,655 Editas Medicine shares in Q1 2021, an estimated $536K.
Allianz Asset Management first reported a position in Editas Medicine in Q3 2017 and held it in 8 quarters.
Allianz Asset Management's Editas Medicine position peaked at $5.62M in Q2 2018.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.